ranolazine has been researched along with Cardiomyopathy, Dilated in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aljassim, O; Bonadei, I; Bontempi, L; Curnis, A; D'Aloia, A; Raweh, A; Salghetti, F; Vizzardi, E | 1 |
Balijepalli, RC; Belardinelli, L; Hacker, TA; Markandeya, YS; Tsubouchi, T; Wolff, MR | 1 |
Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP | 1 |
Aiba, T; Begley, MJ; Boström, P; Cantley, LC; Das, S; del Monte, F; Ellinor, PT; Graham, EL; Hessler, K; Knight, AC; Morissette, MR; Ottaviano, FG; Quintero, PA; Rosenberg, M; Rosenzweig, A; Tomaselli, GF; Xiao, C | 1 |
4 other study(ies) available for ranolazine and Cardiomyopathy, Dilated
Article | Year |
---|---|
Efficacy of ranolazine in a patient with idiopathic dilated cardiomyopathy and electrical storm.
Topics: Acetanilides; Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiography; Heart Rate; Humans; Male; Piperazines; Ranolazine; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2013 |
Inhibition of late sodium current attenuates ionic arrhythmia mechanism in ventricular myocytes expressing LaminA-N195K mutation.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Disease Models, Animal; Heart Ventricles; Lamin Type A; Mice; Mutation, Missense; Myocytes, Cardiac; Ranolazine; Sodium Channel Blockers; Sodium Channels | 2016 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Hypoglycemia; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Sotalol; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2011 |
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling.
Topics: Acetanilides; Animals; Cardiomegaly, Exercise-Induced; Cardiomyopathy, Dilated; Consensus Sequence; Disease Models, Animal; Electrocardiography; Enzyme Induction; Heart Failure; Humans; Hypertension; Immediate-Early Proteins; Ion Channel Gating; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Protein Interaction Mapping; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Ranolazine; Sodium Channel Blockers; Tachycardia, Ventricular; Ventricular Remodeling | 2012 |